Cargando…
New developments in the pharmacotherapy of neuropathic chronic pelvic pain
Advancements in further understanding the pathophysiology of chronic pelvic pain syndromes continue to direct therapy. The mechanisms of chronic pelvic pain are often multifactorial and therefore require a multidisciplinary approach. The final treatment plan is often an accumulation of organ-specifi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242194/ https://www.ncbi.nlm.nih.gov/pubmed/28116131 http://dx.doi.org/10.4155/fsoa-2016-0048 |
_version_ | 1782496307398574080 |
---|---|
author | Carey, Erin T As-Sanie, Sawsan |
author_facet | Carey, Erin T As-Sanie, Sawsan |
author_sort | Carey, Erin T |
collection | PubMed |
description | Advancements in further understanding the pathophysiology of chronic pelvic pain syndromes continue to direct therapy. The mechanisms of chronic pelvic pain are often multifactorial and therefore require a multidisciplinary approach. The final treatment plan is often an accumulation of organ-specific treatment and chronic pain medications directed to the CNS and PNS. This article is a review of commonly used medications for chronic pelvic neuropathic pain disorders as well as an introduction to recent innovative developments in pain medicine. |
format | Online Article Text |
id | pubmed-5242194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Future Science Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-52421942017-01-23 New developments in the pharmacotherapy of neuropathic chronic pelvic pain Carey, Erin T As-Sanie, Sawsan Future Sci OA Review Advancements in further understanding the pathophysiology of chronic pelvic pain syndromes continue to direct therapy. The mechanisms of chronic pelvic pain are often multifactorial and therefore require a multidisciplinary approach. The final treatment plan is often an accumulation of organ-specific treatment and chronic pain medications directed to the CNS and PNS. This article is a review of commonly used medications for chronic pelvic neuropathic pain disorders as well as an introduction to recent innovative developments in pain medicine. Future Science Ltd 2016-10-05 /pmc/articles/PMC5242194/ /pubmed/28116131 http://dx.doi.org/10.4155/fsoa-2016-0048 Text en © Erin T Carey, MD MSCR This work is licensed under a Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Review Carey, Erin T As-Sanie, Sawsan New developments in the pharmacotherapy of neuropathic chronic pelvic pain |
title | New developments in the pharmacotherapy of neuropathic chronic pelvic pain |
title_full | New developments in the pharmacotherapy of neuropathic chronic pelvic pain |
title_fullStr | New developments in the pharmacotherapy of neuropathic chronic pelvic pain |
title_full_unstemmed | New developments in the pharmacotherapy of neuropathic chronic pelvic pain |
title_short | New developments in the pharmacotherapy of neuropathic chronic pelvic pain |
title_sort | new developments in the pharmacotherapy of neuropathic chronic pelvic pain |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242194/ https://www.ncbi.nlm.nih.gov/pubmed/28116131 http://dx.doi.org/10.4155/fsoa-2016-0048 |
work_keys_str_mv | AT careyerint newdevelopmentsinthepharmacotherapyofneuropathicchronicpelvicpain AT assaniesawsan newdevelopmentsinthepharmacotherapyofneuropathicchronicpelvicpain |